Investing.com - Phenixfin (NASDAQ: PFX) reported second quarter EPS of $0.28, $0.51 worse than the analyst estimate of $0.79. Revenue for the quarter came in at $4.66M versus the consensus estimate of $5.6M.
Phenixfin's stock price closed at $45.00. It is up 0.56% in the last 3 months and up 30.42% in the last 12 months.
Phenixfin saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Phenixfin's stock price’s past reactions to earnings here.
According to InvestingPro, Phenixfin's Financial Health score is "good performance".
Check out Phenixfin's recent earnings performance, and Phenixfin's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar